Stocks in focus; WPI & CPI numbers eyed

Stocks that you need to keep a tab on for today

SI Reporter Mumbai
Last Updated : Jul 14 2014 | 8:36 AM IST
The markets are likely to open on a flat note tracking mixed global cues. In addition, WPI and CPI numbers which are due to be released today will be keenly watched by the market participants. 
 
Asian share markets edged higher on Monday as euro zone banking jitters faded, to be replaced by caution ahead of corporate earnings and a raft of global economic events including testimony from the head of the Federal Reserve.SGX Nifty is quoting at 7,478.50 lower by 0.04% 
 
MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS was up 0.2 percent, with Seoul .KS11 putting on 0.4 percent. Japan's Nikkei .N225 rose a modest 0.2 percent after several sessions of losses.
 
European markets had calmed on Friday as investors decided that losses associated with the founding family of Banco Espirito Santo (BES.LS) were unlikely to disrupt Portugal's financial system or revive broader worries about the bloc's weaker economies.
 
Stocks to watch:
 
Tata Power, which is pursuing “aggressive growth plans”, has sought shareholders’ nod to raise up to Rs 7,000 crore through issue of non-convertible debentures (NCDs). Besides, the leading private power utility has proposed increasing its borrowing limit to Rs 27,000 crore.
 
Renewable energy generator Welspun Energy Pvt Ltd (WEPL) has started work for setting up of 50-MW solar project at Baramati Maharashtra. The company is setting up the project on a public-private partnership (PPP) model with Maharashtra State Power Generation Company, Welspun Energy said in a statement.
 
Tata group's flagship Jaguar Land Rover (JLR) is developing much smarter cars that will offer a completely personalised driving experience and help prevent accidents by reducing driver distraction.
 
 Polaris Financial Technology is likely to remain in focus after Orbitech Limited sold 6,16,400 shares of  Polaris at Rs 226.93.
 
Sun Pahrma is likely to remain in focus after Caraco Pharmaceutical Laboratories, a subsidiary of Sun Pharma  , has decided to recall some lots of Venlafaxine Hydrochloride extended-release tablets from the US market. According to a notification by the FDA, the recall of 26,530 units of 30-count bottles and 14,597 units of 90-count bottles is voluntarily initiated by the company through a letter to the regulator last month under 'Class-II' classification. 
 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 14 2014 | 8:32 AM IST

Next Story